Somali Misra Burgess
Somali draws from her almost 18 years of consulting experience and three years of pharmaceutical industry experience to provide clients with the appropriate COA-related solutions. Prior to joining Evidera, she was a senior director and PRO thought leader at Xcenda. Other positions she has held include CEO and research director at Strategic Outcomes Services, a boutique consulting company that specialized in the development, validation, and evaluation of COAs and regulatory strategy; vice president on the Endpoint Development and Outcomes Assessment group at Adelphi Values; and, director in the GHEOR division at Allergan heading up products/indications in Allergan medical, health, and medical dermatology. Somali has extensive experience developing and demonstrating value arguments for new and existing products/indications, COA evaluations, questionnaire development and validation, endpoint development, patient-centric research, and global regulatory strategies and submissions. Her therapeutic areas of expertise include, but are not limited to, aesthetic indications, medical dermatology, gastrointestinal conditions, urology, ophthalmology, and respiratory conditions. Somali has experience developing regulatory strategies and supporting submissions to Asia-Pacific regulatory agencies.
Somali has a PhD in pharmacoeconomics and outcomes research from the College of Pharmacy, University of Georgia. She is a member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the International Society for Quality of Life Research (ISOQOL).